A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

The ketogenic diet added to usual care may offer a small benefit for treatment-resistant depression, the authors concluded.

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Google will partner with Included Health to launch a nationwide randomized study evaluating how conversational artificial intelligence performs in real-world virtual care workflows. Here are four thin ...

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, ...

Physician coaching is emerging as a valuable approach to reduce burnout and enhance well-being across medical training and ...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

A novel collaboration may establish a framework to help researchers overcome regulatory barriers they often face when ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the ...